Non-alcoholic fatty liver disease differential diagnosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2] Parth Vikram Singh, MBBS[3]
Overview
Overview
Usually, NAFLD presents with no or few symptomsΒ but if symptomatic NAFLD must be differentiated from other diseases that cause jaundice and abdominal pain which include Wilson’s disease, hemochromatosis, alcoholic hepatitis and cholestatic jaundice.
Differential Diagnosis
Differential Diagnosis
NAFLD must be differentiated from other diseases that cause jaundice and abdominal pain like including alcohol-associated liver disease, metabolic dysfunction and alcohol-related liver disease, drug-induced liver injury, hepatitis C virus infection, iron overload, celiac disease, HIV infection, malnutrition, Wilson disease, lysosomal acid lipase deficiency, hypobetalipoproteinemia, and inborn errors of metabolism.[1][2]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
References
- β Abd El-Kader SM, El-Den Ashmawy EM (2015). “Non-alcoholic fatty liver disease: The diagnosis and management”. World J Hepatol. 7 (6): 846β58. doi:10.4254/wjh.v7.i6.846. PMCΒ 4411527. PMIDΒ 25937862.
- β Tilg H, Petta S, Stefan N, Targher G (January 2026). “Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review”. JAMA. 335 (2): 163β174. doi:10.1001/jama.2025.19615. PMIDΒ 41212550 Check
|pmid=value (help).
Looking for the patient version?
Β© 2026 MyEClinic β IFTM Institut fΓΌr Telematik in der Medizin GmbH
